Literature DB >> 9013432

Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus.

C G Basualdo1, E E Wein, T K Basu.   

Abstract

OBJECTIVE: Poorly controlled insulin-dependent diabetes mellitus (IDDM) has been reported to be associated with an impaired metabolic availability of vitamin A. The purpose of this study was to examine vitamin A status in a select group with non-insulin dependent diabetes mellitus (NIDDM).
METHODS: Participants included 106 (male, female, > 40 years) Plains Cree adults residing in central Alberta, with NIDDM (n = 59) and non-diabetic controls (n = 47). Non-fasting plasma samples were collected and concentrations of retinol, zinc, alpha-tocopherol, total protein, albumin, retinol binding protein (RBP), transthyretin (TTR), cholesterol, triglycerides, glucose, insulin, and fructosamine were determined. Multiple linear regression was used to identify predictors of plasma RBP concentration. Three repeated 24-hour recalls and a food frequency questionnaire were used to determine vitamin A intakes.
RESULTS: Diabetic subjects had similar intake and plasma concentration of vitamin A compared to controls. Factors such as alpha-tocopherol, zinc, total protein, albumin, and TTR, which are known to influence vitamin A metabolism, also remained unaffected in subjects with diabetes. Plasma levels of vitamin A carrier protein (RBP), however, were elevated in diabetic subjects, possibly as a result of hyperinsulinemia. The subjects with diabetes had many characteristics of the insulin resistant syndrome, including central obesity, hypertension, and hypertriglyceridemia. Poor metabolic control, based on plasma glucose, was a significant predictor of RBP concentration in diabetic subjects.
CONCLUSIONS: The plasma concentration of RBP was elevated in diabetic subjects and was associated with normal circulatory availability of retinol. The subjects with NIDDM, characterized by insulin resistance without insulin deficiency, thus, appear to be associated with normal vitamin A status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013432     DOI: 10.1080/07315724.1997.10718647

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  25 in total

Review 1.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

2.  Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects.

Authors:  T E Graham; C J Wason; M Blüher; B B Kahn
Journal:  Diabetologia       Date:  2007-02-09       Impact factor: 10.122

3.  High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.

Authors:  Amar B Singh; Rakeshwar S Guleria; Irina T Nizamutdinova; Kenneth M Baker; Jing Pan
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

4.  Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys.

Authors:  May A Beydoun; J Atilio Canas; Hind A Beydoun; Xiaoli Chen; Monal R Shroff; Alan B Zonderman
Journal:  J Nutr       Date:  2012-07-18       Impact factor: 4.798

5.  Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys.

Authors:  May A Beydoun; Monal R Shroff; Xiaoli Chen; Hind A Beydoun; Youfa Wang; Alan B Zonderman
Journal:  J Nutr       Date:  2011-03-30       Impact factor: 4.798

Review 6.  Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress.

Authors:  T K Young; J Reading; B Elias; J D O'Neil
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

7.  Retinol-binding protein 4 : a possible role in cardiovascular complications.

Authors:  Jogeswar Mohapatra; Manoranjan Sharma; Aviseka Acharya; Gaurav Pandya; Abhijit Chatterjee; R Balaraman; Mukul R Jain
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

8.  Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.

Authors:  Charles A Steiner; Andrej Janez; Mojca Jensterle; Katrin Reisinger; Thomas Forst; Andreas Pfützner
Journal:  J Diabetes Sci Technol       Date:  2007-03

9.  Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.

Authors:  Aiwei Yao-Borengasser; Vijayalakshmi Varma; Angela M Bodles; Neda Rasouli; Bounleut Phanavanh; Mi-Jeong Lee; Tasha Starks; Leslie M Kern; Horace J Spencer; Amir Adel Rashidi; Robert E McGehee; Susan K Fried; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

10.  Vitamin A: a missing link in diabetes?

Authors:  Steven E Trasino; Lorraine J Gudas
Journal:  Diabetes Manag (Lond)       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.